ISE Chemicals Corporation (TYO:4107)
Japan · Delayed Price · Currency is JPY 3,880.00
-35.00 (-0.89%)
Sep 18, 2026, 3:30 PM JST
ISE Chemicals Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 39,213 | 39,258 | 33,287 | 26,413 | 25,564 | 20,354 | |
Revenue Growth | 5.31% | 17.94% | 26.02% | 3.32% | 25.60% | 20.73% |
Cost of Revenue | 27,138 | 26,857 | 23,178 | 19,027 | 19,892 | 15,906 |
Gross Profit | 12,075 | 12,401 | 10,109 | 7,386 | 5,672 | 4,448 |
Selling, General & Admin | 2,877 | 2,507 | 2,105 | 1,789 | 1,624 | 1,443 |
Research & Development | 370 | 370 | 306 | 260 | 260 | 264 |
Operating Expenses | 3,286 | 2,916 | 2,450 | 2,089 | 1,915 | 1,738 |
Operating Income | 8,789 | 9,485 | 7,659 | 5,297 | 3,757 | 2,710 |
Interest Expense | -5 | -4 | -2 | -1 | -1 | -1 |
Interest & Investment Income | 39 | 21 | 12 | 5 | 3 | 6 |
Currency Exchange Gain (Loss) | -244 | -251 | -233 | -185 | -103 | -25 |
Other Non Operating Income (Expenses) | 2 | 1 | - | - | - | -3 |
EBT Excluding Unusual Items | 8,581 | 9,252 | 7,436 | 5,116 | 3,656 | 2,687 |
Gain (Loss) on Sale of Assets | - | - | 2 | 4 | 3 | - |
Asset Writedown | -82 | -103 | -29 | -101 | -76 | -96 |
Other Unusual Items | -5 | -1 | 1 | 180 | 15 | - |
Pretax Income | 8,494 | 9,148 | 7,410 | 5,199 | 3,598 | 2,591 |
Income Tax Expense | 2,490 | 2,650 | 2,339 | 1,527 | 1,036 | 818 |
Net Income | 6,004 | 6,498 | 5,071 | 3,672 | 2,562 | 1,773 |
Net Income to Common | 6,004 | 6,498 | 5,071 | 3,672 | 2,562 | 1,773 |
Net Income Growth | -2.25% | 28.14% | 38.10% | 43.33% | 44.50% | 32.02% |
Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 | 51 |
Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 | 51 |
Shares Change | -0.01% | -0.00% | -0.02% | -0.02% | - | -0.02% |
EPS (Basic) | 117.82 | 127.51 | 99.51 | 72.04 | 50.26 | 34.78 |
EPS (Diluted) | 117.82 | 127.51 | 99.51 | 72.04 | 50.26 | 34.78 |
EPS Growth | -2.24% | 28.14% | 38.13% | 43.35% | 44.50% | 32.04% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 5,696 | 5,091 | 689 | 2,490 | 75 | 5 |
Free Cash Flow Per Share | 111.78 | 99.90 | 13.52 | 48.85 | 1.47 | 0.10 |
Dividend Per Share | 40.000 | 39.000 | 36.000 | 27.000 | - | 12.000 |
Dividend Growth | 2.56% | 8.33% | 33.33% | - | - | 33.33% |
Gross Margin | 30.79% | 31.59% | 30.37% | 27.96% | 22.19% | 21.85% |
Operating Margin | 22.41% | 24.16% | 23.01% | 20.05% | 14.70% | 13.31% |
Profit Margin | 15.31% | 16.55% | 15.23% | 13.90% | 10.02% | 8.71% |
Free Cash Flow Margin | 14.53% | 12.97% | 2.07% | 9.43% | 0.29% | 0.03% |
EBITDA | 11,078 | 11,531 | 9,634 | 7,267 | 5,569 | 4,199 |
EBITDA Margin | 28.25% | 29.37% | 28.94% | 27.51% | 21.79% | 20.63% |
D&A For EBITDA | 2,289 | 2,046 | 1,975 | 1,970 | 1,812 | 1,489 |
EBIT | 8,789 | 9,485 | 7,659 | 5,297 | 3,757 | 2,710 |
EBIT Margin | 22.41% | 24.16% | 23.01% | 20.05% | 14.70% | 13.31% |
Effective Tax Rate | 29.32% | 28.97% | 31.56% | 29.37% | 28.79% | 31.57% |